메뉴 건너뛰기




Volumn 12, Issue 4, 2013, Pages 497-505

Risks associated with the therapeutic use of fluoroquinolones

Author keywords

Fluoroquinolones; Paediatrics; Quinolones; Safety; Tolerability

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; CEFUROXIME AXETIL; CIPROFLOXACIN; CLARITHROMYCIN; COTRIMOXAZOLE; FLUCLOXACILLIN; FLUCONAZOLE; GATIFLOXACIN; LEVOFLOXACIN; MOXIFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

EID: 84879374553     PISSN: 14740338     EISSN: 1744764X     Source Type: Journal    
DOI: 10.1517/14740338.2013.796362     Document Type: Review
Times cited : (109)

References (56)
  • 1
    • 15944424472 scopus 로고    scopus 로고
    • Adverse effects
    • Hooper D, Rubinstein E, editors American Society for Microbiology, Washington;
    • Lode H, Rubinstein E. Adverse effects. In: Hooper D, Rubinstein E, editors. Quinolone antimicrobial agents. 3rd edition. American Society for Microbiology, Washington; 2003. p. 407-19
    • (2003) Quinolone Antimicrobial Agents. 3rd Edition , pp. 407-419
    • Lode, H.1    Rubinstein, E.2
  • 2
    • 21844444791 scopus 로고    scopus 로고
    • Antimicrobial safety: Focus on fluoroquinolones
    • Owens RC Jr, Ambrose PG. Antimicrobial safety: focus on fluoroquinolones. Clin Infect Dis 2005;41(Suppl 2):S144-57 (Pubitemid 40962485)
    • (2005) Clinical Infectious Diseases , vol.41 , Issue.2 SUPPL.
    • Owens Jr., R.C.1    Ambrose, P.G.2
  • 3
    • 65949098180 scopus 로고    scopus 로고
    • Safety profile of the respiratory fluoroquinolone moxifloxacin: Comparison with other fluoroquinolones and other antibacterial classes
    • van Bambeke F, Tulkens PM. Safety profile of the respiratory fluoroquinolone moxifloxacin: comparison with other fluoroquinolones and other antibacterial classes. Drug Saf 2009;32:359-578
    • (2009) Drug Saf , vol.32 , pp. 359-578
    • Van Bambeke, F.1    Tulkens, P.M.2
  • 4
    • 77951107090 scopus 로고    scopus 로고
    • Safety profile of the fluoroquinolones: Focus on levofloxacin
    • Liu HH. Safety profile of the fluoroquinolones: focus on levofloxacin. Drug Saf 2010;33:353-69
    • (2010) Drug Saf , vol.33 , pp. 353-369
    • Liu, H.H.1
  • 5
    • 0001424862 scopus 로고    scopus 로고
    • Safety overview. Toxicity adverse effects and drug interactions
    • Andriole V editor Academic Press London
    • Stahlmann R, Lode H. Safety overview. Toxicity, adverse effects, and drug interactions. In: Andriole V, editor. The Quinolones. 3rd edition. Academic Press, London; 2000. p. 397-453
    • (2000) The Quinolones. 3rd Edition , pp. 397-453
    • Stahlmann, R.1    Lode, H.2
  • 6
    • 0037186895 scopus 로고    scopus 로고
    • Clinical toxicological aspects of fluoroquinolones
    • DOI 10.1016/S0378-4274(01)00509-4, PII S0378427401005094
    • Stahlmann R. Clinical toxicological aspects of fluoroquinolones. Toxicol Lett 2002;127:269-77 (Pubitemid 34615518)
    • (2002) Toxicology Letters , vol.127 , Issue.1-3 , pp. 269-277
    • Stahlmann, R.1
  • 7
    • 84867330853 scopus 로고    scopus 로고
    • Improving known classes of antibiotics: An optimistic approach for the future
    • Bush K. Improving known classes of antibiotics: an optimistic approach for the future. Curr Opin Pharmacol 2012;12:527-34
    • (2012) Curr Opin Pharmacol , vol.12 , pp. 527-534
    • Bush, K.1
  • 9
    • 84863676446 scopus 로고    scopus 로고
    • Current status of Clostridium difficile infection epidemiology
    • Lessa FC, Gould CV, McDonald LC. Current status of Clostridium difficile infection epidemiology. Clin Infect Dis 2012;55(Suppl 2):S65-70
    • (2012) Clin Infect Dis , vol.55 , Issue.SUPPL. 2
    • Lessa, F.C.1    Gould, C.V.2    McDonald, L.C.3
  • 11
    • 80455173556 scopus 로고    scopus 로고
    • Host and pathogen factors for Clostridium difficile infection and colonization
    • Loo VG, Bourgault AM, Poirier L, et al. Host and pathogen factors for Clostridium difficile infection and colonization. N Engl J Med 2011;365:1693-703
    • (2011) N Engl J Med , vol.365 , pp. 1693-1703
    • Loo, V.G.1    Bourgault, A.M.2    Poirier, L.3
  • 12
    • 79958808865 scopus 로고    scopus 로고
    • Hepatic safety of antibiotics used in primary care
    • Andrade RJ, Tulkens PM. Hepatic safety of antibiotics used in primary care. J Antimicrob Chemother 2011;66:1431-46
    • (2011) J Antimicrob Chemother , vol.66 , pp. 1431-1446
    • Andrade, R.J.1    Tulkens, P.M.2
  • 13
    • 84867173455 scopus 로고    scopus 로고
    • Canadian drug safety and effectiveness research network. fluoroquinolone therapy and idiosyncratic acute liver injury: A population-based study
    • Paterson JM, Mamdani MM, Manno M, Juurlink DN. Canadian drug safety and effectiveness research network. fluoroquinolone therapy and idiosyncratic acute liver injury: a population-based study. CMAJ 2012;184:1565-70
    • (2012) CMAJ , vol.184 , pp. 1565-1570
    • Paterson, J.M.1    Mamdani, M.M.2    Manno, M.3    Juurlink, D.N.4
  • 14
    • 33645833853 scopus 로고    scopus 로고
    • Drug interactions during therapy with three major groups of antimicrobial agents
    • Shakeri-Nejad K, Stahlmann R. Drug interactions during therapy with three major groups of antimicrobial agents. Expert Opin Pharmacother 2006(7):639-51
    • (2006) Expert Opin Pharmacother , vol.7 , pp. 639-651
    • Shakeri-Nejad, K.1    Stahlmann, R.2
  • 16
    • 84859400803 scopus 로고    scopus 로고
    • Oral fluoroquinolones and the risk of retinal detachment
    • Etminan M, Forooghian F, Brophy JM, et al. Oral fluoroquinolones and the risk of retinal detachment. JAMA 2012;307:1414-19
    • (2012) JAMA , vol.307 , pp. 1414-1419
    • Etminan, M.1    Forooghian, F.2    Brophy, J.M.3
  • 17
    • 84869060547 scopus 로고    scopus 로고
    • Association between oral fluoroquinolones and retinal detachment
    • Albini TA, Karakousis PC, Abbey AM, et al. Association between oral fluoroquinolones and retinal detachment. Am J Ophthalmol 2012;154:919-21
    • (2012) Am J Ophthalmol , vol.154 , pp. 919-921
    • Albini, T.A.1    Karakousis, P.C.2    Abbey, A.M.3
  • 18
    • 84872278938 scopus 로고    scopus 로고
    • Flashes, floaters, and oral fluoroquinolones
    • Han DP, Szabo A. Flashes, floaters, and oral fluoroquinolones. Arch Ophthalmol 2013;131:91-3
    • (2013) Arch Ophthalmol , vol.131 , pp. 91-93
    • Han, D.P.1    Szabo, A.2
  • 19
    • 33845512496 scopus 로고    scopus 로고
    • Antimicrobial-associated QT interval prolongation: Pointes of interest
    • DOI 10.1086/508873
    • Owens RC Jr, Nolin TD. Antimicrobial-associated QT interval prolongation: pointes of interest. Clin Infect Dis 2006;43:1603-11 (Pubitemid 44910994)
    • (2006) Clinical Infectious Diseases , vol.43 , Issue.12 , pp. 1603-1611
    • Owens Jr., R.C.1    Nolin, T.D.2
  • 20
    • 83155165270 scopus 로고    scopus 로고
    • QT prolongation and torsade de pointes induced by fluoroquinolones: Infrequent side effects from commonly used medications
    • Briasoulis A, Agarwal V, Pierce WJ. QT prolongation and torsade de pointes induced by fluoroquinolones: infrequent side effects from commonly used medications. Cardiology 2011;120:103-10
    • (2011) Cardiology , vol.120 , pp. 103-110
    • Briasoulis, A.1    Agarwal, V.2    Pierce, W.J.3
  • 21
    • 60749101340 scopus 로고    scopus 로고
    • Effect of macrolide and fluoroquinolone antibacterials on the risk of ventricular arrhythmia and cardiac arrest: An observational study in Italy using case-control, case-crossover and case-time-control designs
    • Zambon A, Polo Friz H, Contiero P, Corrao G. Effect of macrolide and fluoroquinolone antibacterials on the risk of ventricular arrhythmia and cardiac arrest: an observational study in Italy using case-control, case-crossover and case-time-control designs. Drug Saf 2009;32:159-67
    • (2009) Drug Saf , vol.32 , pp. 159-167
    • Zambon, A.1    Polo Friz, H.2    Contiero, P.3    Corrao, G.4
  • 22
    • 84861076083 scopus 로고    scopus 로고
    • Hallet al. Azithromycin and the risk of cardiovascular death
    • Ray WA, Murray KT, Hallet al. Azithromycin and the risk of cardiovascular death. N Engl J Med 2012;366:1881-90
    • (2012) N Engl J Med , vol.366 , pp. 1881-1890
    • Ray, W.A.1    Murray, K.T.2
  • 23
    • 84874099261 scopus 로고    scopus 로고
    • The Effect of combination fluoroquinolone and azole use on QT prolongation in hematology patients
    • Zeuli JD, Wilson JW, Estes LL. The Effect of combination fluoroquinolone and azole use on QT prolongation in hematology patients. Antimicrob Agents Chemother 2013;57:1121-7
    • (2013) Antimicrob Agents Chemother , vol.57 , pp. 1121-1127
    • Zeuli, J.D.1    Wilson, J.W.2    Estes, L.L.3
  • 24
    • 84869026328 scopus 로고    scopus 로고
    • Fluoroquinolones and the risk of serious arrhythmia: A population-based study
    • Lapi F, Wilchesky M, Kezouh A, et al. Fluoroquinolones and the risk of serious arrhythmia: a population-based study. Clin Infect Dis 2012;55:1457-65
    • (2012) Clin Infect Dis , vol.55 , pp. 1457-1465
    • Lapi, F.1    Wilchesky, M.2    Kezouh, A.3
  • 25
    • 28144464151 scopus 로고    scopus 로고
    • A randomized trial comparing the cardiac rhythm safety of moxifloxacin vs levofloxacin in elderly patients hospitalized with community-acquired pneumonia
    • DOI 10.1378/chest.128.5.3398
    • Morganroth J, Dimarco JP, Anzueto A, et al. A randomized trial comparing the cardiac rhythm safety of moxifloxacin vs levofloxacin in elderly patients hospitalized with community-acquired pneumonia. Chest 2005;128:3398-406 (Pubitemid 41698670)
    • (2005) Chest , vol.128 , Issue.5 , pp. 3398-3406
    • Morganroth, J.1    DiMarco, J.P.2    Anzueto, A.3    Niederman, M.S.4    Choudhri, S.5
  • 26
    • 77950203711 scopus 로고    scopus 로고
    • Severe QT interval prolongation associated with moxifloxacin: A case report
    • Koide T, Shiba M, Tanaka K, et al. Severe QT interval prolongation associated with moxifloxacin: a case report. Cases J 2008;1:409
    • (2008) Cases J , vol.1 , pp. 409
    • Koide, T.1    Shiba, M.2    Tanaka, K.3
  • 27
    • 1542316304 scopus 로고    scopus 로고
    • Torsades de pointes associated with fluoroquinolones: Importance of concomitant risk factors
    • DOI 10.1016/j.clpt.2003.11.376, PII S0009923603006349
    • Amankwa K, Krishnan SC, Tisdale JE. Torsades de pointes associated with fluoroquinolones: importance of concomitant risk factors. Clin Pharmacol Ther 2004;75:242-7 (Pubitemid 38314874)
    • (2004) Clinical Pharmacology and Therapeutics , vol.75 , Issue.3 , pp. 242-247
    • Amankwa, K.1    Krishnan, S.C.2    Tisdale, J.E.3
  • 29
    • 33645399023 scopus 로고    scopus 로고
    • Outpatient gatifloxacin therapy and dysglycemia in older adults
    • Park-Wyllie LY, Juurlink DN, Kopp A, et al. Outpatient gatifloxacin therapy and dysglycemia in older adults. N Engl J Med 2006;354:1352-61
    • (2006) N Engl J Med , vol.354 , pp. 1352-1361
    • Park-Wyllie, L.Y.1    Juurlink, D.N.2    Kopp, A.3
  • 30
    • 67651115472 scopus 로고    scopus 로고
    • Severe dysglycemia with the fluoroquinolones: A class effect?
    • Aspinall SL, Good CB, Jiang R et al. Severe dysglycemia with the fluoroquinolones: a class effect? Clin Infect Dis 2009;49:402-8
    • (2009) Clin Infect Dis , vol.49 , pp. 402-408
    • Aspinall, S.L.1    Good, C.B.2    Jiang, R.3
  • 31
    • 77954886592 scopus 로고    scopus 로고
    • Anti-infectives and the risk of severe hypoglycemia in users of glipizide or glyburide
    • Schelleman H, Bilker WB, Brensinger CM, et al. Anti-infectives and the risk of severe hypoglycemia in users of glipizide or glyburide. Clin Pharmacol Ther 2010;88:214-22
    • (2010) Clin Pharmacol Ther , vol.88 , pp. 214-222
    • Schelleman, H.1    Bilker, W.B.2    Brensinger, C.M.3
  • 32
    • 84900348286 scopus 로고
    • Growth inhibition of prematures receiving tetracycline
    • Cohlan SQ, Bevelander G, Tiamsic T. Growth inhibition of prematures receiving tetracycline. Am J Dis Child 1963;105:453-61
    • (1963) Am J Dis Child , vol.105 , pp. 453-461
    • Cohlan, S.Q.1    Bevelander, G.2    Tiamsic, T.3
  • 34
    • 15944373044 scopus 로고    scopus 로고
    • Effects on connective tissue structures
    • Hooper D, Rubinstein E, editors American Society for Microbiology, Washington;
    • Stahlmann R. Effects on connective tissue structures. In: Hooper D, Rubinstein E, editors. Quinolone antimicrobial agents. 3rd edition. American Society for Microbiology, Washington; 2003. p. 441-9
    • (2003) Quinolone Antimicrobial Agents. 3rd Edition , pp. 441-449
    • Stahlmann, R.1
  • 35
    • 60249094709 scopus 로고    scopus 로고
    • Quinolone-induced arthropathy: An update focusing on new mechanistic and clinical data
    • Sendzik J, Lode H, Stahlmann R. Quinolone-induced arthropathy: an update focusing on new mechanistic and clinical data. Int J Antimicrob Agents 2009;33:194-200
    • (2009) Int J Antimicrob Agents , vol.33 , pp. 194-200
    • Sendzik, J.1    Lode, H.2    Stahlmann, R.3
  • 37
    • 84879366097 scopus 로고    scopus 로고
    • Full prescribing information
    • October
    • Bayer. Full prescribing information, Cipro-, October 2011
    • (2011) Cipro
    • Bayer1
  • 38
    • 33845404107 scopus 로고    scopus 로고
    • An open-label, double tympanocentesis study of levofloxacin therapy in children with, or at high risk for, recurrent or persistent acute otitis media
    • DOI 10.1097/01.inf.0000246828.13834.f9, PII 0000645420061200000003
    • Arguedas A, Dagan R, Pichichero M, et al. An open-label, double tympanocentesis study of levofloxacin therapy in children with, or at high risk for, recurrent or persistent acute otitis media. Pediatr Infect Dis J 2006;25:1102-9 (Pubitemid 44900672)
    • (2006) Pediatric Infectious Disease Journal , vol.25 , Issue.12 , pp. 1102-1109
    • Arguedas, A.1    Dagan, R.2    Pichichero, M.3    Leibovitz, E.4    Blumer, J.5    McNeeley, D.F.6    Melkote, R.7    Noel, G.J.8
  • 41
    • 46249118647 scopus 로고    scopus 로고
    • A randomized comparative study of levofloxacin versus amoxicillin/clavulanate for treatment of infants and young children with recurrent or persistent acute otitis media
    • Noel GJ, Blumer JL, Pichichero ME, et al. A randomized comparative study of levofloxacin versus amoxicillin/clavulanate for treatment of infants and young children with recurrent or persistent acute otitis media. Pediatr Infect Dis J 2008;27:483-9
    • (2008) Pediatr Infect Dis J , vol.27 , pp. 483-489
    • Noel, G.J.1    Blumer, J.L.2    Pichichero, M.E.3
  • 42
    • 34848853611 scopus 로고    scopus 로고
    • Will fluoroquinolones ever be recommended for common infections in children?
    • DOI 10.1097/INF.0b013e3180cc20e4, PII 0000645420071000000001
    • Schaad UB. Will fluoroquinolones ever be recommended for common infections in children? Pediatr Infect Dis J 2007;26:865-7 (Pubitemid 47494157)
    • (2007) Pediatric Infectious Disease Journal , vol.26 , Issue.10 , pp. 865-867
    • Schaad, U.B.1
  • 44
    • 78049442053 scopus 로고    scopus 로고
    • Two pediatric cases of multidrug-resistant tuberculosis treated with linezolid and moxifloxacin
    • Pinon M, Scolfaro C, Bignamini E, et al. Two pediatric cases of multidrug-resistant tuberculosis treated with linezolid and moxifloxacin. Pediatrics 2010;126:e1253-6
    • (2010) Pediatrics , vol.126
    • Pinon, M.1    Scolfaro, C.2    Bignamini, E.3
  • 45
    • 47349092626 scopus 로고    scopus 로고
    • Severe acute polyarthritis in a child after high doses of moxifloxacin
    • DOI 10.1080/00365540701849931, PII 791972582
    • Torres JR, Bajares A. Severe acute polyarthritis in a child after high doses of moxifloxacin. Scand J Infect Dis 2008;40:582-4 (Pubitemid 351997683)
    • (2008) Scandinavian Journal of Infectious Diseases , vol.40 , Issue.6-7 , pp. 582-584
    • Torres, J.R.1    Bajares, A.2
  • 46
    • 60649116473 scopus 로고    scopus 로고
    • Death following bilateral complete Achilles tendon rupture in a patient on fluoroquinolone therapy: A case report
    • Gottschalk AW, Bachman JW. Death following bilateral complete Achilles tendon rupture in a patient on fluoroquinolone therapy: a case report. J Med Case Rep 2009;3:1
    • (2009) J Med Case Rep , vol.3 , pp. 1
    • Gottschalk, A.W.1    Bachman, J.W.2
  • 49
    • 0037792114 scopus 로고    scopus 로고
    • Fluoroquinolone-associated tendinopathy: A critical review of the literature
    • DOI 10.1086/375078
    • Khaliq Y, Zhanel GG. Fluoroquinolone-associated tendinopathy: a critical review of the literature. Clin Infect Dis 2003;36:1404-10 (Pubitemid 36702874)
    • (2003) Clinical Infectious Diseases , vol.36 , Issue.11 , pp. 1404-1410
    • Khaliq, Y.1    Zhanel, G.G.2
  • 50
    • 84869228469 scopus 로고    scopus 로고
    • Impact of age, sex, obesity, and steroid use on quinolone-associated tendon disorders
    • Wise BL, Peloquin C, Choi H, et al. Impact of age, sex, obesity, and steroid use on quinolone-associated tendon disorders. Am J Med 2012;125:1228.e23-1228.e28
    • (2012) Am J Med , vol.125
    • Wise, B.L.1    Peloquin, C.2    Choi, H.3
  • 51
    • 20444412319 scopus 로고    scopus 로고
    • Fluoroquinolones cause changes in extracellular matrix, signalling proteins, metalloproteinases and caspase-3 in cultured human tendon cells
    • DOI 10.1016/j.tox.2005.04.002, PII S0300483X05001757
    • Sendzik J, Shakibaei M, Schäfer-Korting M, Stahlmann R. Fluoroquinolones cause changes in extracellular matrix, signalling proteins, metalloproteinases and caspase-3 in cultured human tendon cells. Toxicology 2005;212:24-36 (Pubitemid 40807461)
    • (2005) Toxicology , vol.212 , Issue.1 , pp. 24-36
    • Sendzik, J.1    Shakibaei, M.2    Schafer-Korting, M.3    Stahlmann, R.4
  • 52
    • 76749109407 scopus 로고    scopus 로고
    • Synergistic effects of dexamethasone and quinolones on human-derived tendon cells
    • Sendzik J, Shakibaei M, Schäfer-Korting M, et al. Synergistic effects of dexamethasone and quinolones on human-derived tendon cells. Int J Antimicrob Agents 2010;35:366-74
    • (2010) Int J Antimicrob Agents , vol.35 , pp. 366-374
    • Sendzik, J.1    Shakibaei, M.2    Schäfer-Korting, M.3
  • 53
    • 77950294897 scopus 로고    scopus 로고
    • Safety and tolerability of commonly prescribed oral antibiotics for the treatment of respiratory tract infections
    • Lode H. Safety and tolerability of commonly prescribed oral antibiotics for the treatment of respiratory tract infections. Am J Med 2010;123:S26-38
    • (2010) Am J Med , vol.123
    • Lode, H.1
  • 54
    • 77949366024 scopus 로고    scopus 로고
    • Safety considerations of fluoroquinolones in the elderly: An update
    • Stahlmann R, Lode H. Safety considerations of fluoroquinolones in the elderly: an update. Drugs Aging 2010;27:193-209
    • (2010) Drugs Aging , vol.27 , pp. 193-209
    • Stahlmann, R.1    Lode, H.2
  • 55
    • 84872184684 scopus 로고    scopus 로고
    • Unnecessary antimicrobial use in patients with current or recent Clostridium difficile infection
    • Shaughnessy MK, Amundson WH, Kuskowski MA, et al. Unnecessary antimicrobial use in patients with current or recent Clostridium difficile infection. Infect Control Hosp Epidemiol 2013;34:109-16
    • (2013) Infect Control Hosp Epidemiol , vol.34 , pp. 109-116
    • Shaughnessy, M.K.1    Amundson, W.H.2    Kuskowski, M.A.3
  • 56
    • 84867387020 scopus 로고    scopus 로고
    • Geriatric pharmacology and pharmacotherapy education for health professionals and students: A systematic review
    • Keijsers CJ, van Hensbergen L, Jacobs L, et al. Geriatric pharmacology and pharmacotherapy education for health professionals and students: a systematic review. Br J Clin Pharmacol 2012;74:762-73
    • (2012) Br J Clin Pharmacol , vol.74 , pp. 762-773
    • Keijsers, C.J.1    Van Hensbergen, L.2    Jacobs, L.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.